Сравнение

Icatibant vs. Vasopressin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

138614-30-9

нет данных

Молекулярная масса

1304.52 g/mol

1084.23 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Icatibant

Icatibant competitively blocks the bradykinin B2 receptor. Because bradykinin mediates the vascular permeability, swelling and pain typical of hereditary angioedema, the blockade interrupts the acute attack.

Vasopressin

Vasopressin binds V1 receptors (vasoconstriction, raising vascular resistance) and V2 receptors (renal water reabsorption via aquaporin channels). This raises blood pressure and acts antidiuretically. Desmopressin is the V2-selective synthetic analog.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Icatibant	Vasopressin
Германия	Рецептурный	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Icatibant and Vasopressin?: Icatibant is classified as "Исследования (прочее)", while Vasopressin is classified as "Исследования (прочее)". Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Icatibant or Vasopressin?: The highest available evidence level is "РКИ на людях" for Icatibant and "РКИ на людях" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Icatibant and Vasopressin in Germany and the United States?: Германия: Icatibant — Рецептурный, Vasopressin — Рецептурный. США: Icatibant — Рецептурный, Vasopressin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Icatibant

Vasopressin

Германия

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Icatibant and Vasopressin?

Icatibant is classified as "Исследования (прочее)", while Vasopressin is classified as "Исследования (прочее)". Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). Vasopressin: Vasopressin (arginine vasopressin, antidiuretic hormone/ADH) is a cyclic nonapeptide hormone that regulates water balance and vascular tone. As Vasostrict it is approved to raise blood pressure in vasodilatory shock. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Icatibant or Vasopressin?

The highest available evidence level is "РКИ на людях" for Icatibant and "РКИ на людях" for Vasopressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Icatibant and Vasopressin in Germany and the United States?

Германия: Icatibant — Рецептурный, Vasopressin — Рецептурный. США: Icatibant — Рецептурный, Vasopressin — Рецептурный. These are factual summaries with source and review date on the individual pages.